Latest Opioid Stories
DALLAS, December 12, 2014 /PRNewswire/ -- RnRMarketResearch.com adds "Opioids Market Overview to 2023 - Opioids in Emerging Markets" industry research report with latest
Concerns about prescription drug abuse and addiction may affect prescribing habits, survey suggests
First-in-class treatment approved for adult patients with opioid-induced constipation who have had an inadequate response to laxatives SAN FRANCISCO, Dec.
A new study finds that mindfulness can bring back happiness in people falling down the rabbit hole of opioid drug addiction.
A study just released compared the use of prescription opioids and stimulants among high school graduates, non-graduates, and their college-attending peers, and found that young adults who do not attend college are at particularly high risk for nonmedical prescription opioid use and disorder.
Lightlake Therapeutics advances collaboration with NIDA for novel intranasal naloxone application to reverse opioid overdose LONDON, Dec.
Pain Insights, Inc.
WALTHAM, Massachusetts, December 3, 2014 /PRNewswire/ -- EarlySense [http://www.earlysense.com ](R), the market leader in contact free monitoring solutions announced today
Novel Product Virtually Devoid of Opioid Activity Being Studied in Neuropathic Pain. NEW YORK, Dec. 2, 2014 /PRNewswire/ -- Relmada Therapeutics, Inc.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.